Tikva Allocell closes $8 million Series A financing led by Kantharos Capital to advance engineered EBV-specific T-cell therapy for solid tumors.
Amount Raised
$8 Million
Round Type
Series A
SingaporeBiotechnologyHealth CareTherapeuticsInvestors
Description
Tikva Allocell Pte. Ltd., a biotechnology company, has closed an $8 million Series A financing. The financing will support the completion of IND-enabling activities and a planned year-end IND submission for its lead CAR-T candidate, TAVST01, targeting solid tumors. The company aims to initiate a Phase 1 clinical trial for advanced B7-H3-positive cancer
Quick answer
Tikva Allocell Pte. Ltd raised $8 Million in a Series A round, dated July 22, 2026. Investors: Kantharos Capital. Tikva Allocell Pte. Ltd is based in Singapore.
- How much did Tikva Allocell Pte. Ltd raise?
- Tikva Allocell Pte. Ltd raised $8 Million in a Series A round on July 22, 2026.
- Who invested in Tikva Allocell Pte. Ltd?
- Kantharos Capital is named as investors in this round.
- What does Tikva Allocell Pte. Ltd do?
- Tikva Allocell Pte. Ltd. is a biotechnology company developing engineered, allogeneic (donor-derived) cell therapies for adult and pediatric patients with solid tumors.
- Where is Tikva Allocell Pte. Ltd based and how big is it?
- Tikva Allocell Pte. Ltd is based in Singapore. Fundz records about 11 employees.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Tikva Allocell Pte. Ltd that raised within 45 days of this round, from Fundz verified event records.
- Dimerix Limited raised $25M (Debt Financing) on September 4, 2026.
- ZoeNCure Therapeutics Pvt. Ltd raised $2.4M (Seed) on September 3, 2026.
- NovaGo Therapeutics AG raised $30M (Series B) on September 2, 2026.
- Typewriter Therapeutics raised $56M (Series A) on September 2, 2026.
- NovaGo Therapeutics raised $30M (Series B) on September 2, 2026.
- CytoDyn raised $17M on September 1, 2026.
Who to call at Tikva Allocell Pte. Ltd, and when
A new round usually means Tikva Allocell Pte. Ltd is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Tikva Allocell Pte. Ltd raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Tikva Allocell Pte. Ltd, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Tikva Allocell Pte. Ltd. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Tikva Allocell Pte. Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansTikva Allocell Pte. Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.